Please login to the form below
pharma meeting
This page shows the latest pharma meeting news and features for those working in and with pharma, biotech and healthcare.
Lexicon Pharma announces strong CV data for first-in-class sotagliflozin at the European Society of Cardiology’s annual meeting
US-based Lexicon Pharmaceuticals has announced further analyses on the cardiovascular benefits of its first-in-class candidate, sotagliflozin, at the European Society of Cardiology annual meeting.
Latest news
-
Stakeholder meeting kick-starts dialogue on COVID-19 vaccine supply chain issues
The meeting, which took place on 8-9 March, aimed to ‘open dialogue’ around the issues currently surrounding COVID-19 vaccine manufacturing. ... The meeting participants discussed potential solutions to these issues, citing a number of measures to
-
FDA schedules meeting on 26 February to review J&J’s one-dose COVID-19 vaccine
The US Food and Drug Administration (FDA) has scheduled a meeting of an expert advisory committee to discuss the emergence use authorisation for Johnson &Johnson’s (J&J) one-dose
-
In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
Monthly meeting held remotely for the first time due to COVID-19 pandemic. ... The first piece of news to come out of the monthly meeting of the EMA’s human drugs advisory committee – held remotely for the first time – is a green light for
-
Modest meeting sees only two drugs recommended by CHMP
one generic medicine at its latest meeting, with a surprise negative opinion for Eli Lilly’s migraine med Emgality. ... The CHMP recommended a marketing authorisation of Japanese pharma company Shionogi’s antimicrobial drug Fetcroja (cefiderocol) for
-
HIV meeting hears progress towards vaccine and cure
vaccine discovery and translational medicine at J&J’s Janssen pharma unit.
More from news
Approximately 0 fully matching, plus 36 partially matching documents found.
Latest Intelligence
-
Meeting healthcare’s rising challenges
In my view, most disruptive innovation is coming from non-pharma companies and we need to embrace more of those partnerships because we have to transform healthcare. ... Some pharma companies are making progress, and I believe digital innovation could be
-
Future-proofing pharma supply chains by improving inefficiencies in global health architecture
By meeting Pharma 4.0 standards, the sector could increase throughput and reduce cycle times while still maintaining quality. ... Digital inspiration for pharma on mobile, social media, strategy, best practice, regulations and more.
-
Scientific meetings: leveraging on-site, virtual, on-demand and enduring materials
80% valued independent meeting portals supported by pharma. 90% said being able to access information beyond the physical meeting helped them to apply new medical approaches more quickly. ... The benefits for time-poor HCPs are clear, and for pharma
-
Pharma: in search of the sustainable ‘win win’ with the NHS
But how can the pharma industry engage with these new models of care? ... I’ll be chairing Pharma Market Europe and IQVIA’s roundtable next week tackling this central question:.
-
Rare diseases: meeting the challenge
In other words, there are significant gaps - and this is where pharma manufacturers come in. ... is a freelance writer specialising in reports and features for the health and pharma industry.
More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.
Latest appointments
-
Roche's Silvia Ayyoubi retires
Silvia Ayyoubi is to step down as head of group human resources at Roche in the Swiss pharma firm's annual general meeting in March.
-
Merck KGaA adds two to its executive board
It will also see Bernd Reckmann, currently executive board member for life science and performance materials, retire at the German pharma firm's annual general meeting in April.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
How to Increase Engagement During Virtual Events
Tip #2 - Are you team ""jump on a call"" or team ""just email me""? Instead of choosing just one, try using a combination of synchronous (real-time) and asynchronous (over-time, anytime) for your next virtual event. See more tips: . Address:.
-
How to Increase Engagement During Virtual Events
Tip #1 - How can you take your online presentations to the next level? Check out the full list of top 10 tips to increase engagement during virtual events: . Address:. Impetus Digital. WaterPark Place. 20 Bay Street, 11th Floor. Toronto. Ontario.
-
Top 10 Most Important Advisor Questions
I’m excited to share another Impetus top-10 list! This time, I focus on the top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints. Read the full blog article here.
-
From Vision to Action: Medical Affairs’ Time to Lead is Now – Key Themes and Takeaways From the 2022 Medical Affairs Professional Society (MAPS) Global Annual Meeting
Nucleus Global’s Luis Perez shares his thoughts on this year’s meeting. ... Their 2022 Global Annual Meeting included opportunities for networking with pharma/biotech stakeholders and solution vendors/partners and for fostering discussions about hot
-
Case Study: Reducing Travel-Related Emissions and Costs Through Virtual Events
In early 2021, due to COVID-19-related safety concerns and travel and social distancing restrictions, our client needed help to “virtualize” their nationwide, multi-day, multi-business unit internal event with 375 attendees. They wanted to avoid
More from PMHub
Approximately 8 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- PMGroup announces launch of new recruitment platform PharmaRole
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- BioNTech reveals plans to spend about €1bn more on research and development this year
- AstraZeneca’s mild combination asthma reliever approved in UK
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Inizio appoints Stefanie Christmas as global head of DE&I
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
